Document is current
Any future updates will be listed below
-
Authors
Salas-Ramirez, Maikol http://orcid.org/0000-0002-2443-9654
Leube, Julian
Lassmann, Michael
Tran-Gia, Johannes
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (TR 1380/1-1)
Bundesministerium für Bildung und Forschung (13GW0357B)
Universitätsklinikum Würzburg
- License Information
-
More Information
Article History
Received: 9 August 2023
Accepted: 9 February 2024
First Online: 26 February 2024
Declarations
:
: Not applicable.
: Not applicable.
: M. Lassmann has received institutional grants by IPSEN Pharma, Nordic Nanovector, Novartis, and Pentixapharm. No other potential conflicts of interest relevant to this article exist.
